Filing Details

Accession Number:
0001666071-21-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-07 16:14:54
Reporting Period:
2021-01-07
Accepted Time:
2021-01-07 16:14:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1666071 Cardlytics Inc. CDLX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204015 Kirk Somers C/O Cardlytics, Inc.
675 Ponce De Leon Avenue Ne, Suite 6000
Atlanta GA 30308
Chief Legal & Privacy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-07 261 $20.00 59,970 No 4 M Direct
Common Stock Acquisiton 2021-01-07 722 $30.44 60,692 No 4 M Direct
Common Stock Disposition 2021-01-07 983 $135.08 59,709 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-01-07 261 $0.00 261 $20.00
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-01-07 722 $0.00 722 $30.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-12-06 No 4 M Direct
3,185 2027-07-07 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020.
  2. Fully vested.
  3. This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.